Nov 24 Indivior Plc said on Tuesday the U.S. Food and Drug Administration rejected its nasal spray for the emergency treatment of opioid overdose.
These sprays contain naloxone, a drug that has been used to treat opioid overdose for nearly 45 years in injectable forms.
12:07 75 years ago, what if Japan never attacked Pearl Harbor?20
01:40 After Meeting Trump, Japanese Mogul Pledges $50 Billion Investment in the U.S13
05:37 Rodrigo Duterte Says Donald Trump Endorses His Violent Antidrug Campaign11
16:54 A Subdued Putin Calls for ‘Mutually Beneficial’ Relations With the U.S14